Terarecon,Inc.

Terarecon,Inc. has 2 AI-enabled medical devices on the FDA list. The first decision was on November 5, 2024 and the most recent on October 23, 2025 (TeraRecon Cardiovascular.Calcification.CT). Its most common review panel is Radiology (2 devices).